ASO Visual Abstract: Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II-III Lung Adenocarcinoma-A Multicenter CReGYT-03 ALK Study.

Authors

Akira Hamada, Shinkichi Takamori, Asato Hashinokuchi, Mototsugu Shimokawa, Kenichi Suda, Shinya Katsumata, Naoki Haratake, Kotaro Nomura, Yoshihisa Shimada, Takahide Toyoda, Takuya Watanabe, Kazuki Hayasaka, Masaoki Ito, Shuta Ohara, Shota Fukuda, Tomoyo Fukami, Hana Oiki, Kentaro Minegishi, Kantaro Hara, Mao Yoshikawa, Ken Suzawa, Kazuhiko Shien, Kosuke Fujino, Takamasa Koga, Keisuke Kosai, Atsushi Kamigaichi, Hirotsugu Notsuda, Taichi Matsubara, Shinya Tane, Miyuki Abe, Somei Matsuo, Sho Wakasu, Satoshi Muto, Satoru Okada, Tomoki Nishimura, Michihito Toda, Makoto Endo, Kazuki Takada, Keigo Sekihara, Jun Suzuki, Hikaru Watanabe, Ryo Fujikawa, Hironobu Hoshino, Kazuhiko Kuwahara, Norihiko Ikeda, Satoshi Shiono, Junichi Soh, Yasuhisa Ohde, Yasuhiro Tsutani

Published in

Annals of surgical oncology. Oct 23, 2026. Epub Oct 23, 2026.

PMID:
42920049
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.